BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:[ Novartis Forschungsstiftung – FreeNovation | Research funding 
 on biomedical research ]
DTSTART;VALUE=DATE:20210417
DTSTAMP:20260916T191122Z
UID:d81071de665a845583e0479098871e5d225673217c3ab049625aef2a
CATEGORIES:Call for proposal
DESCRIPTION:The Novartis Research Foundation (Novartis Forschungsstiftung)
  has just launched the 2021 FreeNovation thematic call for biomedical rese
 arch projects. Up to 15 projects will be supported with maximum CHF 180’
 000 for 18 months.\n\nThe fields accepted for the 2021 call are:\n\n	Lipid
  therapeutics and signaling\n	Collagen: Homeostasis and dysregulation in d
 isease\n	Bacteria as drugs\n\n\nFor further information on the 2021 fields
 \, have a look at the “call announcement” document in the EPFL Toolkit
 .\n\nProposals must:\n\n\n	Relate to biomedical research with the ultimate
  aim to provide innovative healthcare solutions for patients.\n	Be unconve
 ntional and radical\, with the potential to open up novel research directi
 ons and aiming beyond incremental innovation and discovery.\n	Be particula
 rly original and hard to fund by conventional funding programs due to the 
 “unorthodox” character of the idea or absence of a long-standing acade
 mic reputation held by the researchers.\n	NOT include commercial activitie
 s nor be influenced by commercial interests.\n\n\nInterdisciplinary resear
 ch often has a higher chance of funding.\nResults from preliminary studies
  are NOT a prerequisite. Risk-taking is encouraged.\n\nWho can apply: \n\n
 \n	PhD or equivalent qualification\n	Employed at a reputable healthcare or
  healthcare-related organization\, incl. university\, university hospital 
 or university of applied science in Switzerland throughout the duration of
  the grant.\n	Max. 2 applicants → co-applicants may together submit a si
 ngle proposal. Alternatively\, they can submit two proposals\, but tag the
 m as connected (although connected proposals will be reviewed separately\,
  the benefits of the collaboration will be factored into the evaluation).\
 n\n\nFunding & Duration: Max. CHF 180’000 for up to 18 months\n\nDeadlin
 es:\n\n\n	Please fill out the Institutional Support Letter template availa
 ble in the EPFL Toolkit\, have it signed by the Dean and\, if applicable\,
  by the Director of the Institute and the Head of Unit\, and send it to re
 search@epfl.ch by 6 April 2021 for the institutional signature. \n	Call De
 adline: 17 April 2021 -> submit your proposal by 23:59 CET via FreeNovatio
 n online application portal.\n\n\nProposals will be reviewed anonymously t
 o encourage young scientists and unconventional ideas by an international 
 review committee chaired by Prof. Gerd Folkers (ETHZ) with 6 academic and 
 3 Novartis scientists\, who are experts in the field. Decisions will be co
 mmunicated in mid July 2021.\n\nFor further information\, please have a lo
 ok at the call webpage (in French or German)\, call description (in Englis
 h)\, submission portal\, call guidelines and the EPFL Toolkit.\n 
LOCATION:
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR